[Heparin-like anticoagulant in small cell bronchial carcinoma].
Acquired circulating heparin-like anticoagulants may have different causes, the most frequent being plasmocyte proliferation. The authors report an exceptional case of association between an heparin-like inhibitor and a small-cell anaplastic lung carcinoma, and they review the pathogenesis, laboratory diagnostic methods and treatment of the anticoagulant.
Garnier
G
G
Service de Médecine Interne I, Hôpital de Cimiez, Nice.
Taillan
B
B
Castanet
J
J
Pesce
A
A
Dujardin
P
P
D018288:Carcinoma, Small Cell / Q000097:blood*; D006493:Heparin; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis*; D008175:Lung Neoplasms / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013921:Thrombocytopenia / Q000209:etiology
D007136:Immunoglobulins; C019158:circulating anticoagulants; D006493:Heparin
Anticoagulant circulant "heparine like" au cours d'un carcinome bronchique à petites cellules.